Last Updated: August 25, 2026

Claims for Patent: 11,266,607


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,266,607
Title:Process for the manufacture and use of pancreatin micropellet cores
Abstract:A process for manufacturing and using pancreatin micropellet cores and pancreatin micropellets which are substantially free of synthetic oils. In one embodiment, a pharmaceutical composition is provided comprising a pancreatin micropellet with the enteric coating being designed to deliver pancreatin to the upper portion of the intestine of a mammal for release.
Inventor(s):Shlieout George, Koelln Claus-Juergen, Sczesny Frithjof, Onken Jens, Ruesing Guido
Assignee:ABBVIE PHARMACEUTICALS GMBH
Application Number:US11464704
Patent Claims:

Details for Patent 11,266,607

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. COTAZYM pancrelipase Capsule, Delayed Release 020580 December 09, 1996 11,266,607 2026-08-15
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 April 30, 2009 11,266,607 2026-08-15
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 June 10, 2011 11,266,607 2026-08-15
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.